New Strategies to Prevent Restenosis

Author： Kester M.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.2, 2001-01, pp. : 77-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential new strategies to prevent the development of diabetic retinopathy

By Mohr Susanne  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 189-198

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide-based molecular strategies for restenosis therapy

By Lin Chia-En   Janero David R   Garvey David S  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. : 483-495

Informa Healthcare

Access to resources Recommend Favorite

Can Angiotensin Receptor Antagonists Prevent Restenosis After Stent Placement?

By Peters S.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 143-148

Adis International

Access to resources Recommend Favorite

Celecoxib to prevent restenosis – results from the COREA-TAXUS trial

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 339-341

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2209-2220

Informa Healthcare

Access to resources Recommend Favorite